Introduction {#Sec1}
============

Solid cell nests (SCNs) of the thyroid have fascinated pathologists since they were first described by Getzowa \[[@CR1]\] in 1907. Although it is now widely accepted that SCNs and so-called "mixed" follicles are indeed ultimobranchial body remnants \[[@CR2]--[@CR8]\], their biological significance remains controversial \[[@CR2]--[@CR4], [@CR9], [@CR10]\]. It has been suggested that these embryonic remnants may be the origin of certain ectopic structures rarely reported in thyroid glands \[[@CR3], [@CR6]\] and also of certain types of thyroid tumor \[[@CR9], [@CR10]\]. Moreover, SCNs may be a source of confusion in thyroid pathology, as they can mimic a number of pathological disorders \[[@CR2], [@CR3]\].

Thyroglossal duct cysts, lingual thyroid remnants, and SCNs are believed to harbor pluripotent stem cells \[[@CR2], [@CR3], [@CR7]\]. Solid cell nests are composed of two cell types: "main cells" and "C cells" \[[@CR3]\]. Main cells, which account for a major proportion of SCNs, are polygonal-to-elongated cells with centrally located, oval nuclei; they have uneven nuclear envelopes and occasionally display strongly eosinophilic cytoplasm with squamoid features (including high molecular weight cytokeratins) but lack intercellular bridges \[[@CR3]\]. The minority C cells are characterized by clear cytoplasm and small, compact, centrally located nuclei \[[@CR2]--[@CR4]\]. In up to 81% of cases, mixed follicles may be found admixed with bona fide SCNs \[[@CR2]--[@CR4]\]; these are composed of cells resembling main cells and differentiated follicular cells arranged in a follicular lumen-like pattern.

It has been suggested that main cells might be pluripotent cells contributing to the histogenesis of C cells and follicular cells \[[@CR10]\], as well as to some thyroid tumors \[[@CR11], [@CR12]\], but little research has addressed this hypothesis. If this were the case, main cells might be expected to display a stem cell phenotype, with the capacity both to self-renew and to generate differentiated progeny, as well as the ability to exist in a mitotically quiescent form, although these properties are not always present in all human tissue stem cells \[[@CR13]\].

The present study sought to analyze and characterize thyroid differentiation markers (p63, bcl-2, cytokeratin 19, galectin-3, TTF-1, thyroglobulin, calcitonin) and also stem cell markers (OCT4 and SALL4) in SCNs found in nodular hyperplasia.

Material and Methods {#Sec2}
====================

Formalin-fixed paraffin-embedded tissue sections from ten SCN-containing surgical specimens obtained during total thyroidectomy were retrieved from the files of the Hospital Infanta Luisa (Seville, Spain). Sections were stained with hematoxylin/eosin and evaluated by two pathologists. Patient age, sex, functional status, and underlying SCN-associated thyroid disease are summarized in Table [1](#Tab1){ref-type="table"}. The study was approved by the Hospital Ethical Committee and informed consent was obtained from all participants. Table 1Summary of the patient\'s clinicopathological features and immunostaining findings in solid cell nestsCaseA/ST~3~, T~4,~ TSHPDMain cellsC cellsp63bcl-2CK19GAL-3TGTTF-1\*CTp63bcl-2CK19GAL-3TGTTF-1CT164/FWNLNH++++−−−−−-+−++245/MWNLNH++++−−−−−−+−++343/FWNLNH++++−−−−−−+−++436/FWNLNH++++−−−−−−+−++570/FWNLNH++++−−−−−−+−++637/FWNLNH++++−−−−−−+−++744/MWNLNH++++−−−−−−+−++869/FWNLNH++++−−−−−−+−++962/FWNLNH++++−−−−−−+−++1046/FWNLNH++++−−−−−−+−++*WNL w*ithin normal limits, *PD* pathological diagnosis, *A* age (years)/*S* sex (*F* female, *M* male), *\** 30 % of main cells shown positive immunoreactions, *CK 19* cytokeratin 19, *GAL-3* galectin-3, *TTF-1* thyroid transcription factor, *TG* thyroglobulin, *CT* calcitonin

For immunohistochemical analysis, 4 μm serial sections were stained with a panel of antibodies (Table [2](#Tab2){ref-type="table"}) using the streptavidin--biotin--peroxidase complex technique. Negative (primary antibody replaced by non-immune mouse serum) and positive controls were included in each slide run. All controls gave satisfactory results. A minimum of 10% positive staining was adopted as a cut-off for all markers. For p63 and TTF-1, only nuclear staining was considered specific, while for other markers, only cytoplasmic staining was accepted. Staining for GAL-3 was deemed positive when observed in both nucleus and cytoplasm. Positive nuclear and cytoplasmic staining for OCT4 and SALL4 was evaluated. Table 2Antibodies used for immunohistochemical analysisAntigenAntibodyDilutionCalcitoninPolyclonal (BioGenex, San Ramon CA)1:5,000TTF-18G7G3/1 (Dako, Glustrup, Denmark)1:2,000ThyroglobulinDAK-Tg6 (Dako, Glustrup, Denmark)1:2,000CK 19RCK108 (Dako, Glustrup, Denmark)1:100P634A4 (Dako, Glustrup, Denmark)1:50Bcl-2124 (Dako, Glustrup, Denmark)1:20Galectin-39C4 (Dako, Glustrup, Denmark)1:200*TTF-1* thyroid transcription factor-1, *CK 19* cytokeratin 19

Results {#Sec3}
=======

All tissue sections contained SCNs which are composed of a complex admixture of main cells and C cells, as previously described (Fig. [1a](#Fig1){ref-type="fig"}). Main cells displayed frequent nuclear grooving. Intermingled with main cells, and mainly confined to the periphery of cell nests, C cells were numerically less conspicuous and were characterized by clear or empty cytoplasm and round nuclei. In six cases (60%), solid cell nests contained mixed follicles---structures lined by main cells and follicular epithelium with colloid and/or clumps of eosinophilic material in the lumen (Fig. [1b](#Fig1){ref-type="fig"}). Fig. 1Solid cell nests of the human thyroid. **a**. Solid cell nest composed of a complex admixture of main and C-cell (X 20). **b**. Cystic SCNs. Mixed follicles composed of cells resembling SCN main cells and cuboidal cells arranged in a follicle-like structure (H/E, ×40)

Positive staining for P63 was restricted to SCN main cells (Fig. [2a](#Fig2){ref-type="fig"}). On all sections, C cells stained negative for p63. No positive staining for p63 was observed in adjacent thyroid tissue. Main cells in all tissue sections displayed strong nuclear staining for bcl-2, while staining was negative in C cells (Fig. [2b](#Fig2){ref-type="fig"}). Positive staining for CK19 was observed consistently in main cells, as well in follicular cells of mixed and some adjacent follicles (Fig. [2c](#Fig2){ref-type="fig"}). In all tissue sections, both main cells and C cells showed strong nuclear and cytoplasmic staining for GAL-3 (Fig. [2d](#Fig2){ref-type="fig"}). No positive staining for GAL-3 was detected in adjacent thyroid tissue. Fig. 2Immunohistochemical analysis. **a**. p63, strong nuclear staining in main cells (×40). **b**. bcl-2, strong cytoplasmic staining in main cells (×40).**c**. CK19, moderate cytoplasmic staining in main cells (×40). **d**. GAL-3, strong cytoplasmic, and nuclear staining. Positive staining in both main and C cells. **e**, **f** TG and PTH, negative staining in both main and C cells (×40). **g** CT, moderate cytoplasmic staining in C cells (×20). **h** TTF-1, moderate nuclear staining in a small number of SCN cells, mainly those forming mixed follicles (×40)

TG is considered the most specific marker of thyroid follicular differentiation. Here, none of the SCNs stained positive for TG (Fig. [2e](#Fig2){ref-type="fig"}). Conversely, thyroid follicular cells and colloid were strongly positive for TG. CT staining was detected in C cells of all SCNs and in parafollicular cells of adjacent thyroid tissue (Fig. [2g](#Fig2){ref-type="fig"}). Positive staining for TTF-1 was detected in all differentiated cells of the thyroid parenchyma and in a few SCN cells, mainly those forming mixed follicles (Fig. [2h](#Fig2){ref-type="fig"}). Positive staining for PTH was not detected either in SCNs or in surrounding thyroid tissue (Fig. [2f](#Fig2){ref-type="fig"}). Immunohistochemical findings and clinical data are summarized in Table [1](#Tab1){ref-type="table"}.

Only two cases showed granular cytoplasmic staining to be negative in all cases for SALL4.

Discussion {#Sec4}
==========

Solid cell nests may pose a challenge to the thyroid specialist, since they may be confused with squamous metaplasia, metastatic squamous carcinoma, papillary microcarcinoma, medullary carcinoma, and C cell hyperplasia C \[[@CR2], [@CR3]\]. It has been assumed that a histological evaluation based on the "typical" immunohistochemical profile of SCNs (CEA and cytokeratins) should be sufficient to distinguish them from their mimics \[[@CR2], [@CR3]\]. However, since CEA and cytokeratins are also coexpressed in some neuroendocrine carcinomas \[[@CR10], [@CR14]\], other more specific markers are required.

As reported by other authors \[[@CR15]\], expression of GAL-3 in the present study was sufficiently restricted to SCNs. Moreover, positive staining for p63 was detected in SCN main cells but not in surrounding thyroid tissue. Other authors report similar findings \[[@CR11], [@CR12], [@CR16]\], adding that p63 is not expressed in certain differentiated carcinomas (medullary and follicular) \[[@CR12], [@CR17]\] and indeed is only exceptionally expressed in foci of squamous metaplasia in papillary carcinomas \[[@CR18]\]. Thus, p63 may prove a highly effective marker for distinguishing SCNs from other pathologies.

Although there is no precise definition of stem cells, it is generally understood that they exhibit the capacity both to self-renew and to generate differentiated progeny, as well as the ability to exist in a mitotically quiescent form, although these properties are not always present in all human tissue stem cells \[[@CR13]\].

P63 is a structural homolog belonging to the p53 tumor suppressor family involved in the survival and differentiation of stem cells in various epithelia \[[@CR19], [@CR20]\]. It has been suggested that p63 may trigger the differentiation of certain specific cell lines \[[@CR19]--[@CR21]\]. In addition, strong bcl-2 expression was detected here in main cells; this is characteristic of a non-committed embryonic phenotype associated with stem cells \[[@CR22]\].

Main cells stained negative for two differentiation markers, PTH and TG; this allowed SCNs to be distinguished from parathyroid tissue remnants and suggested the absence of main cell differentiation towards TG-producing follicular cells. However, positive staining for CT was occasionally detected in SCN cells which resembled parafollicular cells in surrounding thyroid tissue, suggesting an intra-SCN differentation of this cell line. Positive staining for TTF-1 was detected in some peripheral SCN cells; to judge by the findings of other authors, these were probably C cells \[[@CR21]\]. Positive TTF-1 staining was also noted in mixed follicle cells and in all follicles in surrounding thyroid tissue. The hypothesis regarding the embryonic nature of SCNs is borne out by the fact that TTF-1---an early marker of thyroid cell differentiation \[[@CR23], [@CR24]\]---was not expressed by most SCN cells (undifferentiated cells). The putative stem cell role of SCNs is further supported by the continuity observed between main cells, mixed follicles, and follicular and parafollicular cells. This strongly suggests that, as reported by other authors, SCN main cells may be pluripotent cells contributing to the histogenesis of C cells and follicular cells as well as to some thyroid tumors \[[@CR10]\]. This hypothesis is borne out by the immunohistochemical profile of SCNs obtained in the present study and by the findings of other authors who report a marked capacity for self-renewal (telomerase activity) a and low proliferation index in these cells \[[@CR11]\].

Until now, SCNs have been seen solely as a morphological feature of thyroid tissue; a number of hypotheses have been put forward regarding their nature and their purpose. The results of the present study using stem cell markers failed to confirm the initial hypothesis, since OCT4 protein expression---whose significance is uncertain---was detected in only two cases, and SALL4 expression in none. Future research should thus focus on other specific stem cell markers (e.g., NANOG, SOX2).

As part of the general quest to identify specific stem cell populations in a range of organs and tissues in both healthy and sick patients \[[@CR25], [@CR26]\], a number of authors have postulated a stem cell role for SCNs in the thyroid gland \[[@CR10]\]; some studies have even linked them to the genesis of several tumors, including papillary, mucoepidermoid, and squamous carcinoma \[[@CR10], [@CR11], [@CR27]\]. Attempts have also been made to demonstrate the presence the same BRAF mutation (V600E) in SCNs and in micropapillary carcinoma \[[@CR16]\]. There appears to be no evidence to support the link between SCNs and medullary carcinoma posited by a several authors \[[@CR4], [@CR28]\].

The literature, accordingly, contains contradictory views on the potential link between stem cells, SCNs ad thyroid carcinoma; however, all these views are based on immunohistochemical profiles which fail to include absolutely specific stem cell markers \[[@CR29], [@CR30]\]. The present results contribute to a better knowledge of the nature of SCNs and may help clarify the genesis of thyroid tumors; however, they provide no indication of potential therapeutic strategies other than surgery, which for the time being remains the only option.

Further research is required to determine the relationship between main cells and certain thyroid carcinomas, particularly papillary thyroid carcinoma, whose cells---like SCN cells---display strong positive staining for CK 19.
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